Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Moskalev

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Pathogens (Basel, Switzerland)|April 28, 2023
Role of Bacterial Surface Components in the Pathogenicity of <i>Proteus mirabilis</i> in a Murine Model of Catheter-Associated Urinary Tract InfectionRoman Herout, Sara Khoddami, Igor Moskalev, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 24, 2016
Effect of contrast media on urinary cytopathology specimensSebastian Frees, Samir Bidnur, Michael Metcalfe, et al.
Optics Express|June 6, 2019
Multi-octave visible to long-wave IR femtosecond continuum generated in Cr:ZnS-GaSe tandemSergey Vasilyev, Igor Moskalev, Viktor Smolski, et al.
American Journal of Clinical and Experimental Urology|January 31, 2019
Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) modelPeter A Raven, Ninadh M D'Costa, Igor Moskalev, et al.
Optics Express|March 17, 2021
Kerr-lens mode-locked Cr:ZnS oscillator reaches the spectral span of an optical octaveSergey Vasilyev, Igor Moskalev, Viktor Smolski, et al.
European Journal of Immunology|November 23, 2016
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancerLuuk van Hooren, Linda C Sandin, Igor Moskalev, et al.
Theranostics|February 28, 2019
Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First <i>in vivo</i> Results with Uniformly-Sized, Biodegradable Microspheres Labeled with <sup>188</sup>ReJosé Carlos De La Vega, Pedro Luis Esquinas, Cristina Rodríguez-Rodríguez, et al.
The Journal of Urology|June 7, 2015
Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder CancerTetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, et al.
Prostate Cancer and Prostatic Diseases|November 27, 2019
A polymeric paste-drug formulation for intratumoral treatment of prostate cancerClaudia Kesch, Veronika Schmitt, Samir Bidnur, et al.
Oncotarget|June 2, 2018
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinibSebastian Frees, Betty Zhou, Kyung Seok Han, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Pathogens (Basel, Switzerland)|April 28, 2023
Role of Bacterial Surface Components in the Pathogenicity of <i>Proteus mirabilis</i> in a Murine Model of Catheter-Associated Urinary Tract InfectionRoman Herout, Sara Khoddami, Igor Moskalev, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 24, 2016
Effect of contrast media on urinary cytopathology specimensSebastian Frees, Samir Bidnur, Michael Metcalfe, et al.
Optics Express|June 6, 2019
Multi-octave visible to long-wave IR femtosecond continuum generated in Cr:ZnS-GaSe tandemSergey Vasilyev, Igor Moskalev, Viktor Smolski, et al.
American Journal of Clinical and Experimental Urology|January 31, 2019
Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) modelPeter A Raven, Ninadh M D'Costa, Igor Moskalev, et al.
Optics Express|March 17, 2021
Kerr-lens mode-locked Cr:ZnS oscillator reaches the spectral span of an optical octaveSergey Vasilyev, Igor Moskalev, Viktor Smolski, et al.
European Journal of Immunology|November 23, 2016
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancerLuuk van Hooren, Linda C Sandin, Igor Moskalev, et al.
Theranostics|February 28, 2019
Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First <i>in vivo</i> Results with Uniformly-Sized, Biodegradable Microspheres Labeled with <sup>188</sup>ReJosé Carlos De La Vega, Pedro Luis Esquinas, Cristina Rodríguez-Rodríguez, et al.
The Journal of Urology|June 7, 2015
Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder CancerTetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, et al.
Prostate Cancer and Prostatic Diseases|November 27, 2019
A polymeric paste-drug formulation for intratumoral treatment of prostate cancerClaudia Kesch, Veronika Schmitt, Samir Bidnur, et al.
Oncotarget|June 2, 2018
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinibSebastian Frees, Betty Zhou, Kyung Seok Han, et al.
Pageof 4